Abstract:Most agents that damage DNA act through posttranslational modifications of p53 and activate its downstream targets. However, whether cellular responses to nucleoside analogue-induced DNA damage also operate through p53 posttranslational modification has not been reported. In this study, the relationship between p53 activation and its posttranslational modifications was investigated in the human cancer cell lines A549 and HCT116 in response to 5-aza-2 '-deoxycytidine (5-aza-CdR) or cytarabine treatment. 5-Aza-CdR induces p53 posttranslational modifications through activation of an ATM- and Rad3-related (ATR) signaling pathway, and 5-aza-CdR-induced association of replication protein A with chromatin is required for the binding of ATR to chromatin. Upon treatment with 5-aza-CdR, ATR activation is clearly associated with p53 phosphorylation at Ser(15), but not at Thr(18), Ser(20), or Ser(37). This specific p53 phosphorylation at Ser15 in turn results in acetylation of p53 at Lys(320) and Lys(373)/Lys(382) through transcriptional cofactors p300/CBP-associated factor and p300, respectively. These p53 posttranslational modifications are directly responsible for 5-aza-CdR induced p21(Waf1/Cip1) expression because the binding activity of acetylated p53 at Lys(320)/Lys(373)/ Lys(382) to the p21(Waf1/Cip1) promoter, as well as p21(Waf1/Cip1) expression itself are significantly increased after 5-aza-CdR treatment. It is of interest that p53 phosphorylation at Ser15 and acetylations at Lys(320)/Lys(373)/ Lys382 mutually interact in the 5-aza-CdR induced p21(Waf1)/(Cip1) expression shown by transfection of artificially mutated p53 expression vectors including S15A, K320R, and K373R/K382 into p53-null H1299 cells. These data taken together show for the first time that 5-aza-CdR activates the ATR signaling pathway, which elicits a specific p53 phosphorylation-acetylation cascade to induce p21(Waf1/Cip1) expression.

ARF-dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress.

Differential Regulation of Apak by Various Dna Damage Signals

KRAB-type Zinc-Finger Protein Apak Specifically Regulates P53-Dependent Apoptosis

Apak competes with p53 for direct binding to intron 1 of p53AIP1 to regulate apoptosis.

Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression

ARF-mediated SUMOylation of Apak antagonizes ubiquitylation and promotes its nucleolar accumulation to inhibit 47S pre-rRNA synthesis.

Akt-Mediated Phosphorylation of XLF Impairs Non-Homologous End-Joining DNA Repair

ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation.

Chfr and RNF8 Synergistically Regulate ATM Activation

XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification.

ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2

Apurinic/apyrimidinic Endodeoxyribonuclease 1 (APE1) Promotes Stress Granule Formation Via YBX1 Phosphorylation in Ovarian Cancer

A Positive Role for C-Abl in Atm and Atr Activation in DNA Damage Response

A Coordinated Phosphorylation By Lats And Ck1 Regulates Yap Stability Through Scf Beta-Trcp

ArhGAP30 Promotes P53 Acetylation and Function in Colorectal Cancer.

Oncogenes & Tumor Suppressors ARF Regulates the Stability of p 16 Protein Via REG g-Dependent Proteasome Degradation

FOXP1 phosphorylation antagonizes its O-GlcNAcylation in regulating ATR activation in response to replication stress

An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of P53/p21waf1/cip1 in Response to 5-Aza-2′-deoxycytidine Treatment

ATM and P21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development.

Data from ARF Regulates the Stability of p16 Protein Via REGγ-Dependent Proteasome Degradation

DNA Damage-Induced Activation of ATM Promotes Β-Trcp-mediated ARID1A Ubiquitination and Destruction in Gastric Cancer Cells